Welcome to the ARCHIVE of Pharma Marketing News Special Reprint Collections. I have assembled these collections so you can get several related reprints in one pdf file at a greatly reduced price compared to ordering them separately. Order and pay online by credit card or e-check for IMMEDIATE delivery of PDF files to you by email. No subscription is required to order reprints or reprint collections.
Direct, Targeted, Permission-based Marketing Builds Relationships, Increases ROI and Improves Patient Compliance
Many experts agree that Relationship Marketing (RM) should be a natural for the pharmaceutical industry, which needs to support the long-term use of their products and help patients remain compliant with their treatment regime.
But not many pharmaceutical marketers understand what relationship marketing is and how it differs from other forms of marketing that they traditionally employ.
This collection of Pharma Marketing News articles, blog posts, and survey results provides you with an excellent introduction to the many facets and uses of pharmaceutical relationship marketing.
approx. 30 pages.
TABLE OF CONTENTS
Relationship Marketing:
Relationship Marketing Program Management for Pharmaceutical Marketers
Evolve Your Brand Into a Relationship With Consumers and Physicians
Out-of-the-Box Marketing: Will It Work for Pharma?
Out-of-the-Box Marketing: Survey Results
Personalized eMarketing: How can you create and profit from a customer's lifetime experience?
Targeted Patient Marketing:
Patient Detailing at the Point of Care
Behavioral Targeting: Pros & Cons
To Build Patient Adherence, Pfizer Puts Technology Behind the Curtain
Leverage Health Beliefs to Develop Effective Online Compliance Programs
Advoy: A Web-based Therapy Management Program
Targeted Physician Marketing:
Marketing to a Segment of One Physician
Whose Data Is It Anyway?
Use of Rx Data Survey Results
Direct to Physician Telemarketing and Sales
Order and pay for this Reprint Collection now using your credit card...ONLY $12.95 Download PDF file immediately after paying:
ePharma Marketing
Volume 1
eMarketing is a challenge for the pharmaceutical industry. It is widely known that the percent of the pharmaceutical marketing budget spent in the "e" space has remained below 5% since the dawn of the commercial Internet!
Many experts, however, believe that pharma eMarketing is at a tipping point and that pharmaceutical companies are poised to shift substantial ad spending from TV and other media to the Internet.
The selection of articles in this Special Supplement to Pharma Marketing News was chosen to give you a better perspective on pharma eMarketing. Included are real world case studies that illustrate the advantages of eMarketing such as depth of information, interaction, relationship building and superior customer engagement.
approx. 45 pages.
TABLE OF CONTENTS
Regulations, Laws, Best Practices, Trends:
Applying FDA Marketing Regulations to Internet Promotions... pg. 2
E-mail Marketing Best Practices for Pharma... pg. 4
Some State and Federal Laws Impacting E-mail Marketing... pg. 6
Physician-focused eMarketing:
eDetailing: Yesterday, Today and Tomorrow... pg. 9
The Role of Tablet PCs in Pharma Sales and Marketing... pg. 13
DocCheck: Das Portal... pg. 16
How European Physicians use the Internet... pg. 17
The European eMarketing Scene... pg. 20
European Online Marketing and eDetailing Survey Results... pg. 24
ePrescribing: What Role Should Pharma Play?... pg. 25
Consumer-focused eMarketing:
Searching for Answers on Search Engine Marketing?... pg. 28
The Absolute, Relative, and Incremental ROI of DTC eMarketing... pg. 31
cDetailing: Addressing the Consumer Education Gap... pg. 33
Blogs and the Pharmaceutical Industry... pg. 36
Paid Inclusion: Too Hot for Pharma Marketing?... pg. 39
Online Health-Related Stats Cited by Google... pg. 40
Can Health Web Sites Improve Compliance?... pg. 44
Order and pay for this Reprint Collection now using your credit card...ONLY $19.95 Download PDF file immediately after paying:
Physician Education
Key Opinion Leaders, Medical Science Liaisons, & CME
It's a new era for pharmaceutical company support of physician education. New guidelines and regulations from various governmental and non-governmental regulatory bodies have come into play during the past few years. The second event defining this new era was the withdrawal of Vioxx from the market in 2004 and the subsequent re-emergence of the importance of physicians as "learned intermediaries."
More than ever, it is important to educate physicians about new drugs and to keep this education separate from the marketing function of the company yet aligned with commercial goals.
This Special Supplement to Pharma Markeing News is critical reading for pharmaceutical companies and physician education service providers wishing to understand the new roles of key opinion leader physicians (KOLs) and medical science liaisons (MSLs) in the physician education process.
approx. 27 pages.
TABLE OF CONTENTS
Regulations & Guidelines:
Compliance with (Some) ACCME Rules Not So Easy... pg. 2
Return on Physician Education... pg. 4
PhRMA Code Helps Re-define Roles of Medical Affairs and Marketing... pg. 5
Responding to the Challenges of Evolving Regulation... pg. 8
Thought-Leader Management: A Challenge Met... pg. 12
Medical Science Liaisons: Working between Two Worlds... pg. 14
MSL Role in Educational Development... pg. 17
Motivating & Retaining the MSL: What Makes MSLs Tick... pg. 18
Managing Medical Science Liaisons from Afar... pg. 19
Give Docs What They Want... pg. 20
CME:
Provider-Pharmaceutical Partnerships: Are They Possible Without Conflict of Interest?... pg.21
When Is Commercial Support Appropriate for CME Activities?... pg. 22
Return on CME: Are Pharma Companies Getting Desired Outcomes?... pg. 24
A Strategic Approach to CME Offers High Return on Education Investment... pg. 26
Order and pay for this Reprint Collection now using your credit card...ONLY $19.95 Download PDF file immediately after paying:
eDetailing
Non-personal Physician Sales techniques
In the rush to gain Share of Voice by increasing the frequency and reach of sales calls, pharmaceutical companies may have lost sight of the value that the "detail person" has given to physicians in past years.
The declining sales force return on investment may signal that a significant adjustment will take place in how pharma companies market and sell their products to physicians. Many experts--not the least of which are the experts cited in this Special Supplement--think that eDetailing fits the bill for a solution to declining physician marketing ROI.
This Special Supplement to Pharma Marketing News brings together in one convenient document several topics and case studies on eDetailing and ePromotion to physicians.
The resultant collective wisdom of many experts both inside pharmaceutical companies and outside provide a frank assessment of the role and impact of eDetailing on physician marketing as well as the challenges that lie ahead.
eDetailing Strategies for a Higher Physician Response... pg. 2
The Impact of eDetailing... pg. 5
Why Pharma Can't Ignore eDetailers... pg. 7
Optimizing eDetailing ROI... pg. 9
The Future of eDetailing... pg. 11
Intelligent Online Sampling Strategies... pg. 13
A Private-label, Turnkey eDetailing Solution at a Fixed Fee Price... pg. 16
eDetailing Solution as Part of a Cross-Channel Strategic Relationship... pg. 17
Online Detailing as an Adjunct to a Part-time CSO Sales Force... pg. 18
Expanding New Patient Starts Through Broader Physician Sample Coverage... pg. 19
List of Resources & Experts Cited... pg. 20
LIST OF FIGURES
Physicians who use the Internet for work-related activities (US only)
ePromotion Activities and Expenditures
ePromotion Activities by Activity Type
Benchmark Study and Online survey of eDetailed physicians: Doctors prefer eDetails with honoraria
Benchmark Study and Online survey of eDetailed physicians: Prescribers respond favorably to eDetailing
e-Detailing vs. Overall Sales and Promotion. eDetailing and promotion budgets through the product life cycle
"Doorknob Details Study": Sales force effectiveness parameters
Computing in the Physicians' Practice
Fixed Price eDetailing Solution: Cost per detail
US promotional Spending by Pharma Breakout
Impact of Sampling on Physician Prescribing
Pharmaceutical Marketing Influence on Physician Prescribing
Percent of Physicians Rating Information Services Good or Excellent (Internet, Reps, Journals, Symposia)
PDR Subscriber Survey
MD Consult Survey
Get this reprint collection FREE!
Use Discount Code 'eDFREE' when ordering...
Sales Force Effectiveness
Increase Physician Access and Detailing Effectiveness
Everyone knows that pharma sales reps are less effective than they used to be. Although the pharmaceutical sales force has doubled between 1995 and 2000, the number of audited calls has only increased by 10%.
Through articles and real-world case studies this Special Supplement presents the collective wisdom of many marketing experts who offer solutions to the problem of decreasing sales rep effectiveness and decreasing return on the physician marketing dollar.
The information in this Special Supplement is certain to give you a better understanding of the issues relating to physician access and how to improve the effectiveness of your physician marketing and sales campaigns.
approx. 26 pages.
TABLE OF CONTENTS
A Crisis in Professional Detailing... pg. 2
Marketing's Role in Limiting Physician Access... pg. 4
Finding the "Right Stuff" to Revitalize Sales Productivity... pg. 6
Facilitating Physician Access and Education Through Online Conferencing... pg. 7
The Targeted Model... pg. 9
Limbic Market Research... pg. 11
Intelligent Online Sampling Strategies... pg. 13
Increase Prescription Sales with Smart Tools at the Point of Care... pg. 16
A Novel Approach to Communicating with Physicians... pg. 18
Increase Sales Representative Performance and Productivity by Building Collaborative Physician Relationships... pg. 20
Promoting Pull Through Prescriptions via Value-Added Free Medical Practice Web Sites and Patient Education... pg. 21
Gauging Physician Behavior and CE Impact with Two-Way, Real Time, Web-Based Technology... pg. 22
Live, Online, Interactive Conference with Experts to Provide Detailed Product Information to Physicians... pg. 23
Audio with Synchronized Visuals Streaming Over Low Bandwidth Internet Connections for Physician Detailing... pg. 24
Online Content Management System for Sales and Marketing Representatives... pg. 25
LIST OF FIGURES
Percentage of Physicians Indicating Sales Rep Attribute is Valuable
US promotional Spending by Pharma Breakout
Impact of Sampling on Physician Prescribing
Pharmaceutical Marketing Influence on Physician Prescribing
Percent of Physicians Rating Information Services Good or Excellent (Internet, Reps, Journals, Symposia)
PDR Subscriber Survey
MD Consult Survey
Sources for Learning Prescribing Information
Order and pay for this reprint now using your credit card...ONLY $19.95 Download PDF file immediately after paying:
SPECIAL!
Case Studies and Reviews featuring innovative Products and Services for Pharmaceutical Marketing and Sales. Presents Practical Solutions from leading vendors and suppliers.
Pharma Marketing News is the periodic electronic newsletter of the Pharma
Marketing Network (www.pharma-mkting.com). Pharma Marketing Network
is an exclusive marketing information resource and communications
network for pharmaceutical marketing professionals.
Each issue of Pharma Marketing News is packed with facts,
opinions, and case studies based upon interviews with experts in
the field of pharmaceutical marketing. Highlights of presentations
from industry conferences and links to references help subscribers keep up to date on best
practices and network with their peers.